Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Safforia is a private consumer health and wellness company that markets saffron-based functional beverages and dietary supplements. The brand positions saffron as a mood-supporting and wellness ingredient and sells ready-to-drink elixirs as well as a mood-and-immunity supplement directly to consumers through its e-commerce site. Its flagship commercial products include the Gold Rush saffron passionfruit elixir, Bliss Royale, and a tablet-based Mood & Immunity Supplement. The company appears to operate as a nutraceutical and functional wellness brand rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Safforia.